Pioneering a novel approach to
treating chronic disease with
SHIELDED LIVING THERAPEUTICS™
Learn moreOur Purpose
Serious chronic diseases today are often treated with chronic therapies. For patients with diseases such as lysosomal diseases or type 1 diabetes, they often are treated with frequent injections or infusions — sometimes multiple times daily — and constant, lifelong vigilance to manage their disease.
We developed our Shielded Living Therapeutics™ platform to address these treatment challenges. Leveraging advances in cell engineering and our proprietary biocompatible materials, we created a pipeline of potential therapies capable of producing proteins, enzymes and other therapeutic molecules that may be missing or deficient in the body—potentially resulting in functional cures for patients with a wide range of chronic diseases.